Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pituitary|November 8, 2011
Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotideElisabeth Couture, Vanina Bongard, Jean-Christophe Maiza, et al.
The Annals of Pharmacotherapy|March 8, 2007
Gynecomastia associated with fenofibrateVirginie Gardette, Delphine Vezzosi, Jean-Christophe Maiza, et al.
Pituitary|January 12, 2011
Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotideJean-Christophe Maiza, Stéphane Castillo-Ros, Maria Matta, et al.
European Journal of Endocrinology|April 8, 2011
Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatmentMaria Matta, Vanina Bongard, Solange Grunenwald, et al.
European Journal of Endocrinology|May 10, 2013
Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemiaAlexandre Buffet, Delphine Vezzosi, Jean Christophe Maiza, et al.
Clinical Endocrinology|September 11, 2008
High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidismPhilippe Caron, Jean Christophe Maiza, Claire Renaud, et al.
Clinical Endocrinology|May 26, 2007
Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTaJean Christophe Maiza, Delphine Vezzosi, Maria Matta, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2013
Virilizing sclerosing-stromal tumor of the ovary in a young woman with McCune Albright syndrome: clinical, pathological, and immunohistochemical studiesKahina Boussaïd, Geri Meduri, Jean-Christophe Maiza, et al.
Clinical Endocrinology|April 28, 2011
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivationPhilippe Caron, William F Simonds, Jean-Christophe Maiza, et al.
Diabetes & Metabolism|November 18, 2022
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetesGuillaume Treiber, Alice Guilleux, Kevin Huynh, et al.
Pageof 2